To investigate if recombinant human laminin-111 could prevent disease progression, we generated an immunodeficient dyW mouse model of laminin-α2-related congenital muscular dystrophy (LAMA2-CMD). The gene discussed is LAMA2; the disease is congenital muscular dystrophy due to LMNA mutation.